Studies on interaction of norfloxacin, Cu2+, and DNA by spectral methods

Journal of Fluorescence

Volumn 15, Issue 5, 2005, Pages 673-678

  Song, Gongwu ^a   Yan, Qiujun ^a   He, Yu ^b  

^a HUBEI UNIVERSITY   (China)

^b NONE

Author keywords

Cu2+; DNA; Fluorescence; Norfloxacin; Static quenching style

Indexed keywords

CONCENTRATION (PROCESS); COPPER; DNA; FLUORESCENCE; QUENCHING; ULTRAVIOLET RADIATION;

BINARY COMPLEX; CU2+; NORFLOXACIN; STATIC-QUENCHING STYLE;

ANTIBIOTICS;

COPPER; DIVALENT CATION; DNA; NORFLOXACIN;

ARTICLE; CALIBRATION; CHEMISTRY; DNA DENATURATION; OSMOLARITY; PH; SPECTROFLUOROMETRY; TEMPERATURE; ULTRAVIOLET SPECTROPHOTOMETRY;

CALIBRATION; CATIONS, DIVALENT; COPPER; DNA; HYDROGEN-ION CONCENTRATION; NORFLOXACIN; NUCLEIC ACID DENATURATION; OSMOLAR CONCENTRATION; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE;

EID: 29144525015     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-005-2974-8     Document Type: Article

References (24)

1. Y. Jenkins, A. E. Friedman, N. J. Turro, and J. K. Barton (1992). Characterization of dipyridophenazine complexes of ruthenium(II): The light switch effect as a function of nucleic acid sequence and conformation. Biochem. 31, 10809-10816.
2. M. Gellert, K. Mizuuchi, M. H. O'Dea, and H. A. Nash (1976). DNA Gyrase: An enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. U.S.A. 73, 3872-3876.
3. M. Gellert, K. Mizuuchi, M. H. O'Dea, T. Itoh, and J. Tomizawa (1977). Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. U.S.A. 74, 4772-4776.
4. A. Sugino, C. L. Peebles, K. N. Kreuzer, and N. R. Cozzarelli (1977). Mechanism of action of nalidixic acid: Purification of escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc. Natl. Acad. Sci. U.S.A. 74, 4767-4771.
5. M. G. Cormican, S. A. Marshall, R. N. Jones (1995). Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levoftoxacin, ofloxacin, and sparfloxacin). 22, 51.
6. L. L. Shen, L. A. Mitscher, P. N. Sharm, T. J. O'Donnell, W. T. D. Chu, C. S. Cooper, T. Rosen, and A. G. Pernet (1989). Mechanism of inhibition of DNA gyrase by quinolone antibacterials: A cooperative drug-DNA binding model. Biochemicals 28, 3886.
7. L. L. Shen and A. G. Pernat (1985). Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: The target of the drugs is DNA. Proc. Natl. Acad. Sci. U.S.A. 82, 307-311.
8. L. L. Shen, J. Baranowski, J. Fostel, D. A. Montgomery, and P. A. Lartey (1992). DNA topoisomerases from pathogenic fungi: Targets for the discovery of antifungal drags. Antimicrob. Agents Chemother. 36, 2778-2784.
9. A. Y. C. Saiki, L. L. Shen, C. M. Chen, J. Baranowski, and C. G. Lerner (1999). DNA cleavage activities of Staphylococeus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridones. Antimicrob. Agents Chemother. 43, 1574-1577.
10. G. Palu, S. Valisena, G. Ciarrocchi, B. Gatto, and M. Palumbp (1992). Quinolone binding to DNA is mediated by magnesium ions. Proc. Natl. Acad. Sci. U.S.A 89, 9671-9675.
11. J. Tuma, W. H. Connors, D. H. Stitelman, and C. Richert (2002). On the effect of covalently appended quinolones on termini of DNA duplexes. Am. Chem. Soc. 124, 4236-4246.
12. V. Cecchetti, O. Tabarrini, et al. (1999). Studies on 6-aminoquinolones: Synthesis and antibacterial evaluation of 6-amino-8-ethyl- and 6-amino-8-methoxyquinolones. Bioorg. and Med. Chem. 7, 2465-2471.
13. G. S. Son, J. A. Yeo, M. S. Kim, S. K. Kim, and A. Holmen (1998). Binding mode of norfloxacin to calf thymus DNA. Am. Chem. Soc. 120, 6451-6457.
14. S. Tornaletti and A. M. Pedrini (1988). Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments. Biochim. Biophys. Acta. 949, 279.
15. 2-. Int. J. Pharmaceut. 164, 57-65.
16. S. Q. Wu, W. J. Zhang, X. G. Chen, Z. D. Hu, M. Hooper, B. Hooper, Z. F. Zhao (2001). Fluorescence characteristic study of the ternary complex of fluoroquinolone antibiotics and cobalt (II) with ATP. Spectrochim. Acta Part A: Mol. Biomol. Specrtosc. 57, 1317-1323.
17. X. Y. Yuan, L. Chen, J. L. Qiao (1999). Study on the ternary complex of CPFX, Copper(II) and DNA by the method of fluorescence. Spectroscopy and Spectral Anal. 19, 572-574.
18. 2+-mediated binding of 6-substituted quinolones to DNA: Relevance to biological activity. Bioorg. Med. Chem. 6, 1555-1561.
19. 2+-ions. Inorg. Chim. Acta 339, 239-247.
20. S. K. Bhowal and T. K. Das (1991). Spectrophotometric determination of some recently introduced antibacterial drugs using ferric chloridd. Anal. Lett. 24, 25.
21. M. D. Bethesda (1988). Drug Information 88, Authority of the Board of Directors of the American Society of Hospital Pharmacists Press, America.
22. J. B. Lippincott (1988). Drug facts and comparison, published by facts and comparision Div., Spain.
23. Y. Xu, H. X. Shen, and H. G. Huan. (1997). Fluorescence characteristics of iron ()-norfloxacin-guanylic acid ternary complex. Anal. Chem. 25, 419.
24. C. W. Kumar, and H. E. Asuncion (1993). DNA binding studies and site selective fluorescence sensitization of an anthryl probe. Am. Chem. Soc. 115, 8547.